Background Myanmar has one of the largest malaria burdens in Southeast Asia. Along the border with Thailand, Plasmodium falciparum parasites are increasingly showing reduced sensitivity to artemisinin combination therapies. Given that there are no current alternative treatment therapies, one proposed solution to the threat of untreatable P. falciparum malaria is to eliminate the parasite from the region. Several small-scale elimination projects have been piloted along the Myanmar-Thailand border. Following their success, this operational research aimed to scale up the elimination to a broad area of Eastern Kayin State, Myanmar. Methods The project relied on geographic reconnaissance and a geographic information system, community engagement,...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
The malaria landscape in the Greater Mekong Subregion has experienced drastic changes with the ramp-...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Thr...
Background Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Thr...
Background Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Thr...
Background Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Thr...
Background: Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Th...
Background: Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Th...
Background: Myanmar has one of the largest malaria burdens in Southeast Asia. Along the border with ...
Background: Myanmar has one of the largest malaria burdens in Southeast Asia. Along the border with ...
Background: Myanmar has one of the largest malaria burdens in Southeast Asia. Along the border with ...
Objectives To document the feasibility of a cross-border community based integrated malaria control ...
Objectives To document the feasibility of a cross-border community based integrated malaria control ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
The malaria landscape in the Greater Mekong Subregion has experienced drastic changes with the ramp-...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Thr...
Background Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Thr...
Background Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Thr...
Background Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Thr...
Background: Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Th...
Background: Myanmar has one of the largest malaria burdens in the Greater Mekong Subregion (GMS). Th...
Background: Myanmar has one of the largest malaria burdens in Southeast Asia. Along the border with ...
Background: Myanmar has one of the largest malaria burdens in Southeast Asia. Along the border with ...
Background: Myanmar has one of the largest malaria burdens in Southeast Asia. Along the border with ...
Objectives To document the feasibility of a cross-border community based integrated malaria control ...
Objectives To document the feasibility of a cross-border community based integrated malaria control ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...
The malaria landscape in the Greater Mekong Subregion has experienced drastic changes with the ramp-...
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater ...